Kolexia
Fonck-Frayssinet Marianne Gastro-entérologie
Fonck-Frayssinet Marianne
Gastro-entérologie
Institut Bergonié
Bordeaux, France
79 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Métastase tumorale Tumeurs du foie Adénocarcinome Tumeurs du poumon Carcinomes Tumeurs du péritoine Tumeurs du côlon Lymphadénopathie

Collaborateurs

Voir plus
Bechade Dominique
Bechade Dominique
Institut Bergonié, Bordeaux, France
Becouarn Yves
Becouarn Yves
Institut Bergonié, Bordeaux, France
Mathoulin-Pelissier Simone
Mathoulin-Pelissier Simone
Institut Bergonié, Bordeaux, France
Desolneux Gregoire
Desolneux Gregoire
Institut Bergonié, Bordeaux, France

Industries

Voir plus
MSD
2 collaboration(s)
Dernière en 2023
Servier
2 collaboration(s)
Dernière en 2020
Ipsen
1 collaboration(s)
Dernière en 2021
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should mutation research be recommended in everyday practice?
Therapeutic advances in gastroenterology   17 janvier 2024
LBA30 Panitumumab (P) + FOLFIRINOX or mFOLFOX6 in unresectable metastatic colorectal cancer (mCRC) patients (pts) with RAS/BRAF wild-type (WT) tumor status from circulating DNA (cirDNA): First results of the randomised phase II PANIRINOX-UCGI28 study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial.
Nature medicine   10 août 2023
Radiofrequency ablation of lung metastases of colorectal cancer: could early radiomics analysis of the ablation zone help detect local tumor progression?
The British journal of radiology   17 avril 2023
MEDITREME: Phase Ib/II Trial Evaluating the Safety, Tolerability and Immunological Activity of Durvalumab (MEDI4736) (Anti-PD-L1) Plus Tremelimumab (Anti-CTLA-4) Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Essai Clinique (AstraZeneca)   09 février 2023
OMEGA: Phase II Study Evaluating the Efficacy and Tolerance to Chemotherapy With 5-fluorouracil, Folinic Acid, Irinotecan and Bevacizumab as First-line Treatment in Patients With Metastatic Colorectal Cancer
Essai Clinique (Institut Bergonié)   28 octobre 2022
Diagnostic accuracy and clinical impact of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in Positron Emission Tomography - Computed Tomography (PET-CT)-positive mediastinal lymphadenopathies in patients with thoracic or extra-thoracic malignancies.
Clinics and research in hepatology and gastroenterology   25 mars 2022
PHRC2003: Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment . Geriatric Oncology Protocol in Aquitaine Country.
Essai Clinique (BMS)   27 janvier 2022
Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial.
British journal of cancer   06 janvier 2022
Prognostic Value of Routinely Measured Inflammatory Biomarkers in Older Cancer Patients: Pooled Analysis of Three Cohorts.
Cancers   07 décembre 2021